NanoViricides Inc. (NNVC)

[arvitar]

Yeah, that's worked really well for NNVC.

Eleven years and $70M spent, and $730K/year compensation for Seymour and Diwan, not accounting for the 30% indirect costs to Theracour.

But no worries. Clinical trials begin in 1-3 months from now, according to Seymour's last update to the investing public:

"Schedule Reminder

As noted by NNVC in the Jan 2016 Biotech Showcase concerning the lead Herpescide candidate:

May - July: Univ testing to select optimum candidate complete
August - Sept: TOX prep complete
Nov - Dec: TOX package complete
Dec - Feb: Human trials begin"